Dihydropyridines substituées par de 3-quinolyl, procédé pour leur production et leur utilisation dans des médicaments

3-Quinolyl substituted dihydropyridines, process for their preparation and their use in drugs

3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln

Abstract

Die Erfindung betrifft neue 3-Chinolyl substituierte Dihydropyridine der allgemeinen Formel (I) in welcher R 1 bis R 5 die in der Beschreibung angegebene Bedeutung haben, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln, insbesondere in Mitteln zur Behandlung von Herz-Kreislauferkrankungen.
The invention relates to new 3-quinolyl-substituted dihydropyridines of the general formula (I) <IMAGE> in which R1 to R5 have the meaning given in the description, process for their preparation and their use in drugs, in particular in compositions for the treatment of cardiovascular disorders.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (6)

    Publication numberPublication dateAssigneeTitle
    EP-0071819-A1February 16, 1983Bayer AgDihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
    EP-0451654-A2October 16, 1991Bayer AgUse of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation
    EP-0452712-A1October 23, 1991Bayer Ag4-Quinoléyl-dihydropyridines, procédé pour leur préparation et leur utilisation dans des médicaments
    EP-0515940-A1December 02, 1992Bayer AgNeue 2-Amino-5-cyano-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
    EP-0518105-A1December 16, 1992Bayer Ag3-Formyl-1,4-dihydropyridines, process for their preparation and their pharmaceutical use
    EP-0538690-A1April 28, 1993Bayer AgDérivés 1,4-dihydropyridine-dicarboxyliques aryl-quinoline substitués, procédé de préparation et utilisation en tant que médicaments

NO-Patent Citations (1)

    Title
    BARALDI,PG. ET AL.: "Synthesis and Calcium Antagonist Acitivity of Dialkyl 1,4-Dihydro-2,6-dimethyl-4(nitrogenous heteroaryl)-3,5-pyridine dicarboxylates", COLLECT.CZECH.CHEM.COMMUN., vol. 57, 1992, pages 169 - 178, XP009023953, DOI: doi:10.1135/cccc19920169

Cited By (12)

    Publication numberPublication dateAssigneeTitle
    EP-0790826-A1August 27, 1997Synaptic Pharmaceutical CorporationDihydropyrimidines et leurs utilisations
    EP-0790826-A4November 11, 1998Synaptic Pharma CorpDyhydropyrimidine und deren verwendungen
    US-5942517-AAugust 24, 1999Synaptic Pharmaceutical Corporation5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
    US-6172066-B1January 09, 2001Synaptic Pharmaceutical CorporationDihydropyrimidines and uses thereof
    US-6228861-B1May 08, 2001Synaptic Pharmaceutical CorporationDihydropyrimidines and uses thereof
    US-6245773-B1June 12, 2001Synaptic Pharmaceutical Corporation5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
    US-6248747-B1June 19, 2001Synaptic Pharmaceutical Corporation5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
    US-6268369-B1July 31, 2001Synaptic Pharmaceutical Corporation5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
    US-6274585-B1August 14, 2001Synaptic Pharmaceutical CorporationDihydropyrimidines and uses thereof
    US-6680323-B2January 20, 2004Synaptic Pharmaceutical CorporationDihydropyrimidines and uses thereof
    US-6720324-B2April 13, 2004Synaptic Pharmaceutical CorporationSelective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
    US-6727257-B1April 27, 2004Synaptic Pharmaceutical Corporation5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines